<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="uz">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">research-focus</journal-id>
      <journal-title-group>
        <journal-title>Research Focus International Scientific Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Research Focus</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2181-3833</issn>
      <publisher>
        <publisher-name>Ilm-fan va innovatsiyalar akademiyasi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.66073/refocus.v5i8.0810</article-id>
      <article-id pub-id-type="other" assigning-authority="relibrary.uz">REL-A-013565</article-id>
      <article-categories>
        <subj-group subj-group-type="oak">
          <subject>16.00.00</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="uz">Rifizostrep preparatining davolash va profilaktik samaradorligi</article-title>
        <trans-title-group xml:lang="en">
          <trans-title>The therapeutic and preventive effectiveness of the drug Rifizostrep</trans-title>
        </trans-title-group>
        <trans-title-group xml:lang="ru">
          <trans-title>Лечебно-профилактическая эффективность препарата Рифизостреп</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author">
          <name>
            <surname>MAMADULLAYEV</surname>
            <given-names>Gulmurod Hamidovich</given-names>
          </name>
          <aff>Veterinariya ilmiy-tadqiqot instituti, Samarqand, O‘zbekiston</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DJURAKULOV</surname>
            <given-names>Oybek Komiljonovich</given-names>
          </name>
          <aff>Veterinariya ilmiy-tadqiqot instituti, Samarqand, O‘zbekiston</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HAMIDOV</surname>
            <given-names>Siroj Gulmurodovich</given-names>
          </name>
          <aff>Veterinariya ilmiy-tadqiqot instituti, Samarqand, O‘zbekiston</aff>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-09-05">
        <day>05</day>
        <month>09</month>
        <year>2026</year>
      </pub-date>
      <pub-date date-type="collection">
        <year>2026</year>
      </pub-date>
      <volume>5</volume>
      <issue>8</issue>
      <fpage>63</fpage>
      <lpage>66</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0">
          <ali:license_ref>https://creativecommons.org/licenses/by/4.0</ali:license_ref>
          <license-p>Ushbu asar Creative Commons Attribution 4.0 International litsenziyasi asosida litsenziyalangan.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://relibrary.uz/REL-A-013565/"/>
      <abstract xml:lang="uz">
        <p>Maqolada VITI tuberkulyoz laboratoriyasi olimlari tomonidan yaratilgan Rifizostrep preparati bilan qishloq xo‘jalik hayvonlarining bakterial etiologiyali kasalliklarini davolash va profilaktika qilish uslubining ishlab chiqarishga joriy etish natijalari bayon qilingan. Mazkur uslubni tatbiq etilishi natijasida qishloq xo‘jalik hayvonlarining bakterial etiologiyali oftalmologik, respirator, ginekologik va jarroxlik kasalliklarini samarali davolash, shuningdek avitaminozlar profilaktikasini ta‘minlashga erishilgan</p>
      </abstract>
      <trans-abstract xml:lang="en">
        <p>The article presents the results of the introduction of a complex drug – Rifizostrep for the treatment and prevention of bacterial etiology diseases of farm animals developed by Scientific Research Institute of Veterinary scientists. The introduction of this drug made it possible to effectively cure of farm animals from diseases of the organs of sight, respiration, ginecological and surgical diseases of bacterial etiology and also the prevention of avitaminosis.</p>
      </trans-abstract>
      <trans-abstract xml:lang="ru">
        <p>В статье приводятся результаты внедрения в производство комплексного препарата Рифизостреп для лечения и профилактики болезней бактериальной этиологии сельскохозяйственных животных разработанного учеными лаборатории по изучению туберкулёза НИИ ветеринарии. Внедрения данного препарата позволило эффективно вылечит сельскохозяйственных животных от болезней органов зрения, дыхания, гинекологических и хирургических болезней бактериалной этиологии, а также профилактики авитаминозов.</p>
      </trans-abstract>
      <kwd-group xml:lang="uz">
        <kwd>Rifizostrep</kwd>
        <kwd>etiologiya</kwd>
        <kwd>kimyoprofilaktika</kwd>
        <kwd>shtamm</kwd>
        <kwd>bakteriologiya</kwd>
        <kwd>sinergetik</kwd>
        <kwd>prolongatsiya</kwd>
        <kwd>kombinatsiya</kwd>
        <kwd>respirator</kwd>
        <kwd>ginekologik</kwd>
        <kwd>jarrohlik</kwd>
        <kwd>oftalmologik</kwd>
        <kwd>avitaminozlar</kwd>
        <kwd>profilaktika</kwd>
      </kwd-group>
      <kwd-group xml:lang="en">
        <kwd>Rifizostrep</kwd>
        <kwd>etiology</kwd>
        <kwd>chemiciprofilacsis</kwd>
        <kwd>strain</kwd>
        <kwd>bacteriological</kwd>
        <kwd>sinerjis</kwd>
        <kwd>prolonges</kwd>
        <kwd>kombination</kwd>
        <kwd>respirator</kwd>
        <kwd>ginecological</kwd>
        <kwd>oftalmological</kwd>
        <kwd>avitaminosis</kwd>
        <kwd>profilaxis</kwd>
      </kwd-group>
      <kwd-group xml:lang="ru">
        <kwd>Рифизостреп</kwd>
        <kwd>этиология</kwd>
        <kwd>химиопрофилактика</kwd>
        <kwd>штамм</kwd>
        <kwd>бактериология</kwd>
        <kwd>синергетик</kwd>
        <kwd>пролонгация</kwd>
        <kwd>комбинация</kwd>
        <kwd>респиратор</kwd>
        <kwd>гинекологический</kwd>
        <kwd>хирургический</kwd>
        <kwd>офтальмологический</kwd>
        <kwd>авитаминозы</kwd>
        <kwd>профилактика</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref id="r1">
        <label>1</label>
        <mixed-citation>subcutaneous injection a depot forms at the injection site, from which the preparation is absorbed slowly, accumulating maximally in the References (original language) body after 15–20 days and persisting for up to 30 days; the Adabiyotlar matnda birinchi keltirilish tartibida raqamlanadi. Oltitagacha combination of components gives both a synergistic and a prolonging muallif to‘liq ko‘rsatiladi; DOI mavjud bo‘lsa, albatta beriladi. effect. The preparation is injected subcutaneously into the neck, 10–15</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation>Hayvonlar tuberkulyoziga qarshi RIFIZOSTREP preparatini qo‘llash avitaminoses. bo‘yicha uslubiy tavsiyanoma [Methodological recommendation on Conclusion and contribution the use of the RIFIZOSTREP preparation against animal tuberculosis]. Approved by the Veterinary and Livestock The components of Rifizostrep possess a broad antimicrobial Development Committee, 30 April 2024, 7 p. (in Uzbek) spectrum, and their combination confers both synergism and prolongation of action; pharmacokinetically the preparation acts</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
